nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PPARG—nephron—focal segmental glomerulosclerosis	0.315	0.349	CbGeAlD
Balsalazide—PTGS2—nephron—focal segmental glomerulosclerosis	0.161	0.178	CbGeAlD
Balsalazide—PPARG—endothelium—focal segmental glomerulosclerosis	0.149	0.165	CbGeAlD
Balsalazide—PTGS1—endothelium—focal segmental glomerulosclerosis	0.0794	0.088	CbGeAlD
Balsalazide—PTGS2—endothelium—focal segmental glomerulosclerosis	0.0759	0.0841	CbGeAlD
Balsalazide—PPARG—kidney—focal segmental glomerulosclerosis	0.0598	0.0663	CbGeAlD
Balsalazide—PTGS1—kidney—focal segmental glomerulosclerosis	0.032	0.0354	CbGeAlD
Balsalazide—PTGS2—kidney—focal segmental glomerulosclerosis	0.0306	0.0339	CbGeAlD
Balsalazide—PPARG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00989	0.101	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00955	0.0979	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00758	0.0777	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00295	0.0302	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00267	0.0274	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.0025	0.0256	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00234	0.024	CbGpPWpGaD
Balsalazide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.00215	0.0221	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00212	0.0217	CbGpPWpGaD
Balsalazide—PPARG—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.0019	0.0195	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00189	0.0193	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.00185	0.0189	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.00176	0.018	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.00174	0.0178	CbGpPWpGaD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.00172	0.0176	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00166	0.017	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00166	0.017	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00148	0.0152	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00146	0.015	CbGpPWpGaD
Balsalazide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.00142	0.0145	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.00139	0.0143	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.0013	0.0133	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00127	0.013	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00114	0.0117	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00112	0.0115	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.00109	0.0112	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.00109	0.0112	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00107	0.011	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00101	0.0103	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000978	0.01	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000929	0.00953	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000859	0.00881	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00085	0.00871	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000818	0.00839	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000811	0.00831	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000754	0.00773	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000752	0.00771	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.000722	0.0074	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00072	0.00738	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000719	0.00737	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00063	0.00646	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000625	0.00641	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000602	0.00618	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000575	0.0059	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000572	0.00586	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00057	0.00585	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000567	0.00581	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000537	0.0055	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000531	0.00544	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000506	0.00519	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000485	0.00497	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000475	0.00487	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000435	0.00445	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000414	0.00424	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000403	0.00413	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000393	0.00403	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000372	0.00382	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000364	0.00373	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000355	0.00364	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000351	0.0036	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000346	0.00355	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000336	0.00344	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00032	0.00328	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.0003	0.00308	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.00029	0.00297	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000285	0.00293	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000282	0.00289	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000275	0.00282	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000263	0.0027	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000256	0.00263	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—LPL—focal segmental glomerulosclerosis	0.000253	0.00259	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000246	0.00252	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00023	0.00236	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000226	0.00231	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AGT—focal segmental glomerulosclerosis	0.000216	0.00221	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00021	0.00216	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000208	0.00213	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000198	0.00203	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000195	0.002	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000194	0.00199	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000179	0.00184	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000167	0.00171	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ALB—focal segmental glomerulosclerosis	0.000166	0.0017	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000163	0.00167	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000161	0.00165	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000158	0.00162	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—LPL—focal segmental glomerulosclerosis	0.000156	0.0016	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000146	0.00149	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000142	0.00146	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AGT—focal segmental glomerulosclerosis	0.000134	0.00137	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000132	0.00136	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000128	0.00131	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000125	0.00129	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000116	0.00118	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	0.00011	0.00112	CbGpPWpGaD
Balsalazide—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	0.000104	0.00106	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ALB—focal segmental glomerulosclerosis	0.000103	0.00105	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	9.37e-05	0.00096	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	8.69e-05	0.000891	CbGpPWpGaD
Balsalazide—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	8.11e-05	0.000831	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	7.44e-05	0.000762	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	7.19e-05	0.000737	CbGpPWpGaD
Balsalazide—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	6.83e-05	0.0007	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	5.71e-05	0.000585	CbGpPWpGaD
Balsalazide—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	4.31e-05	0.000442	CbGpPWpGaD
